» Articles » PMID: 15737380

In Vitro Chronic Hepatic Disease Characterization with a Multiparametric Ultrasonic Approach

Overview
Journal Ultrasonics
Specialty Radiology
Date 2005 Mar 2
PMID 15737380
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Although, high resolution, real-time ultrasonic (US) imaging is routinely available, image interpretation is based on grey-level and texture and quantitative evaluation is limited. Other potentially useful diagnostic information from US echoes may include modifications in tissue acoustic parameters (speed, attenuation and backscattering) resulting from disease development. Changes in acoustical parameters can be detected using time-of-flight and spectral analysis techniques. The objective of this study is to explore the potential of three parameters together (attenuation coefficient, US speed and integrated backscatter coefficient-IBC) to discriminate healthy and fibrosis subgroups in liver tissue. Echoes from 21 fresh in vitro samples of human liver and from a plane reflector were obtained using a 20-MHz central frequency transducer (6-30 MHz bandpass). The scan plane was parallel to the reflector placed beneath the liver. A 30 x 20 matrix of A-scans was obtained, with a 200-microm step. The samples were classified according to the Metavir scale in five different degrees of fibrosis. US speed, attenuation and IBC were estimated from standard methods described in the literature. Statistical tests were applied to the results of each parameter individually and indicated that it was not possible to identify all the fibrosis groups. Then a discriminant analysis was performed for the three parameters together resulting in a reasonable separation of fibrotic groups. Although the number of tissue samples is limited, this study opens the possibility of enhancing the discriminant capability of ultrasonic parameters of liver tissue disease when they are combined together.

Citing Articles

The relationship between follicle-stimulating hormone and metabolic dysfunction-associated fatty liver disease in men.

Bin D, Liu F, Peng K, Zhan M, Tan Y, Liu Q Nutr Diabetes. 2024; 14(1):52.

PMID: 38991999 PMC: 11239811. DOI: 10.1038/s41387-024-00314-1.


Association between Chinese visceral adiposity index and metabolic-associated fatty liver disease in Chinese adults with type 2 diabetes mellitus.

Tang M, Wei X, Cao H, Zhen Q, Liu F, Wang Y Front Endocrinol (Lausanne). 2022; 13:935980.

PMID: 35979441 PMC: 9376620. DOI: 10.3389/fendo.2022.935980.


Proteomic Analysis of Human Serum for Patients at Different Pathological Stages of Hepatic Fibrosis.

Zhao K, Huang J, Xia H, Zhang J, Liu L Biomed Res Int. 2021; 2021:3580090.

PMID: 34877354 PMC: 8645358. DOI: 10.1155/2021/3580090.


Diagnosis of liver fibrosis in patients with hepatitis B-related liver disease using ultrasound with wave-number domain attenuation coefficient.

He D, Zhang C, Qiu W, Xie Q Turk J Gastroenterol. 2021; 31(12):923-929.

PMID: 33626006 PMC: 7928246. DOI: 10.5152/tjg.2020.20139.


Prevalence, clinical characteristics, risk factors, and indicators for lean Chinese adults with nonalcoholic fatty liver disease.

Zeng J, Yang R, Sun C, Pan Q, Zhang R, Chen G World J Gastroenterol. 2020; 26(15):1792-1804.

PMID: 32351294 PMC: 7183864. DOI: 10.3748/wjg.v26.i15.1792.